Literature DB >> 15751939

Breast cancer in Egypt: a review of disease presentation and detection strategies.

S Omar1, H Khaled, R Gaafar, A R Zekry, S Eissa, O el-Khatib.   

Abstract

Carcinoma of the breast is the most prevalent cancer among Egyptian women and constitutes 29% of National Cancer Institute cases. Median age at diagnosis is one decade younger than in countries of Europe and North America and most patients are premenopausal. Tumours are relatively advanced at presentation. The majority of tumours are invasive duct subtype and the profile of hormone receptors is positive for estrogen receptors and/or progesterone receptors in less than half of cases. This overview examines genetic changes, potential and established predictive and prognostic markers and end results of surgery, radiotherapy and systemic therapy for early, locally advanced and metastatic disease stages. Disease presentations common to the region and early detection strategies are presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15751939

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  26 in total

1.  Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.

Authors:  Adel Denewer; Osama Hussein; Omar Farouk; Waleed Elnahas; Ashraf Khater; Aiman El-Saed
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach.

Authors:  Mohamed El-Shinawi; Sayed F Abdelwahab; Maha Sobhy; Mohamed A Nouh; Bonnie F Sloane; Mona Mostafa Mohamed
Journal:  Ann Surg Oncol       Date:  2010-03-24       Impact factor: 5.344

3.  Gail model utilization in predicting breast cancer risk in Egyptian women: a cross-sectional study.

Authors:  Basem Saleh; Mohamed A Elhawary; Moataz E Mohamed; Islam N Ali; Menna S El Zayat; Hadeer Mohamed
Journal:  Breast Cancer Res Treat       Date:  2021-04-14       Impact factor: 4.872

4.  Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.

Authors:  Safinaz S Ibrahim; Elsayed E Hafez; Mervat M Hashishe
Journal:  J Exp Clin Cancer Res       Date:  2010-06-25

5.  Raising the Breast Health Awareness amongst Women in an Urban Slum Area in Alexandria, Egypt.

Authors:  Ibrahim F Kharboush; Hanaa M Ismail; Alaa A Kandil; Heba M Mamdouh; Yasmine Y Muhammad; Omnia G El Sharkawy; Hassan N Sallam
Journal:  Breast Care (Basel)       Date:  2011-09-14       Impact factor: 2.860

6.  Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.

Authors:  Brooke Spencer; Mousumi Banerjee; Sherif Omar; Hussein Khaled; Nayera Anwar; Mohamed S Zaghloul; Saad Eissa; Celina G Kleer; Subhojit Dey; Sofia D Merajver; Amr S Soliman
Journal:  Breast J       Date:  2011-08-09       Impact factor: 2.431

7.  Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.

Authors:  Azza M Kamel; Salwa Teama; Amal Fawzy; Mervat El Deftar
Journal:  Tumour Biol       Date:  2015-12-18

8.  Breast Cancer in Countries of Limited Resources.

Authors:  Eva J Kantelhardt; Claudia Hanson; Ute-Susann Albert; Jürgen Wacker
Journal:  Breast Care (Basel)       Date:  2008-02-22       Impact factor: 2.860

9.  Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer.

Authors:  Mona Mostafa Mohamed; Dora Cavallo-Medved; Bonnie F Sloane
Journal:  Biol Chem       Date:  2008-08       Impact factor: 3.915

10.  A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.

Authors:  Kelly A Hirko; Amr S Soliman; Mousumi Banerjee; Julie Ruterbusch; Joe B Harford; Sofia D Merajver; Kendra Schwartz
Journal:  Breast J       Date:  2013-12-26       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.